Tim Janssen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tim Janssen has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Kristina M. Jackson
Department of Psychiatry Rutgers Robert Wood Johnson Medical School, New Brunswick NJ USA
10 shared publications - Sara J. Becker
Center for Dissemination and Implementation Science, Northwestern University Feinberg School of Medicine, Chicago, USA
9 shared publications - Anthony Spirito
Alpert Medical School of Brown University
4 shared publications - Joy Gabrielli
University of Florida
4 shared publications - Lourah M. Kelly
Department of Psychiatry, Implementation Science and Practice Advances Research Center, University of Massachusetts Chan School of Medicine, United States of America
4 shared publications - Reinout Wiers
Developmental Psychology, University of Amsterdam
4 shared publications
Latest Publications
- 25 September 2026
- Published by Taylor & Francis in International Journal of Human–Computer Interaction
- p. 1-16
Modeling Daily Digital Experiences in Adolescents: A Multilevel Latent Class Analysis of Social Media Engagement Patterns and Exposure to Alcohol-Related Content
1. Social media plays a central role in contemporary adolescent development, serving not only as a source of entertainment but also as an important space for identity exploration, social comparison...
- 25 September 2026
- Published by Taylor & Francis in International Journal of Human–Computer Interaction
- p. 1-16
Modeling Daily Digital Experiences in Adolescents: A Multilevel Latent Class Analysis of Social Media Engagement Patterns and Exposure to Alcohol-Related Content
1. Social media plays a central role in contemporary adolescent development, serving not only as a source of entertainment but also as an important space for identity exploration, social comparison...
- Open Access
- 22 December 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e83346
Implementation of a Mobile Digital Tool Supporting Medication for Opioid Use Disorder Treatment Improves Retention: Stepped-Wedge Cluster Randomized Controlled Trial
Background: Despite its proven efficacy, retention in medication for opioid use disorder (MOUD) remains low, with structural and systemic barriers—such as access to care and treatment setting—alongside individual factors, including personalization and motivation, contributing to high rates of discontinuation. Digital interventions offer a promising approach to address many of these barriers; however, robust evidence for their effectiveness in improving retention and engagement with treatment remains scarce. Objective: This study aims to evaluate the impact of Recovery Connect—a white-labeled version of Recovery Path and a digital remote patient monitoring app used as part of a blended treatment model for opioid use disorder—on patient retention, treatment continuance, and medication adherence. Methods: A stepped-wedge cluster randomized trial was conducted across 9 outpatient MOUD clinics, organized into 8 clusters. Clusters were sequentially transitioned from usual care to a digitally enhanced model incorporating Recovery Connect, which provided real-time monitoring, psychoeducational and skill-based content, and messaging between patients and clinicians. The primary outcome was 30-day retention in treatment following exposure (implementation of the app in the clinic), linkage (downloading and connecting to the app), or engagement (levels of app usage). Secondary outcomes included treatment continuance—defined as receiving at least 75% of expected doses—and the number of daily doses taken within the first 3, 7, and 30 days after admission. Cluster-controlled discrete-time survival analyses were conducted, adjusting for patient- and clinic-level covariates. Results: Patients admitted to clinics that had implemented the app (n=1205) showed increased retention (922/1205, 75.5%) compared with those in clinics that had not (203/319, 63.6%, P<.001). Patients who downloaded and linked with a mental health professional on Recovery Connect had an 81.3% likelihood of retention, compared with 72.0% (P<.001) among those not linked. Linkage also significantly predicted higher treatment continuance and a greater number of daily doses taken during the first 7 and 30 days (P<.001). Low, moderate, and high engagement levels were associated with progressively higher 30-day retention compared with no engagement (P<.001). Conclusions: This study provides evidence that implementing Recovery Connect (Recovery Path) significantly enhances patient retention and treatment continuity in outpatient opioid use disorder care. Early linkage and engagement during the first week were strong predictors of positive outcomes, underscoring the value of early, proactive digital support. These findings reinforce the effectiveness of blended digital-clinical models, aligning with broader evidence that integrating remote monitoring enhances continuity of care and supports recovery. Policy implications include the need for reimbursement mechanisms, workflow integration, and ethical, privacy-preserving implementation to enable scalable and equitable adoption of digital tools in substance use treatment. Trial Registration: ClinicalTrials.gov NCT07140926; https://clinicaltrials.gov/ct2/show/NCT07140926
- 22 December 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e83346
Open AccessImplementation of a Mobile Digital Tool Supporting Medication for Opioid Use Disorder Treatment Improves Retention: Stepped-Wedge Cluster Randomized Controlled Trial
Background: Despite its proven efficacy, retention in medication for opioid use disorder (MOUD) remains low, with structural and systemic barriers—such as access to care and treatment setting—alongside individual factors, including personalization and motivation, contributing to high rates of discontinuation. Digital interventions offer a promising approach to address many of these barriers; however, robust evidence for their effectiveness in improving retention and engagement with treatment remains scarce. Objective: This study aims to evaluate the impact of Recovery Connect—a white-labeled version of Recovery Path and a digital remote patient monitoring app used as part of a blended treatment model for opioid use disorder—on patient retention, treatment continuance, and medication adherence. Methods: A stepped-wedge cluster randomized trial was conducted across 9 outpatient MOUD clinics, organized into 8 clusters. Clusters were sequentially transitioned from usual care to a digitally enhanced model incorporating Recovery Connect, which provided real-time monitoring, psychoeducational and skill-based content, and messaging between patients and clinicians. The primary outcome was 30-day retention in treatment following exposure (implementation of the app in the clinic), linkage (downloading and connecting to the app), or engagement (levels of app usage). Secondary outcomes included treatment continuance—defined as receiving at least 75% of expected doses—and the number of daily doses taken within the first 3, 7, and 30 days after admission. Cluster-controlled discrete-time survival analyses were conducted, adjusting for patient- and clinic-level covariates. Results: Patients admitted to clinics that had implemented the app (n=1205) showed increased retention (922/1205, 75.5%) compared with those in clinics that had not (203/319, 63.6%, P<.001). Patients who downloaded and linked with a mental health professional on Recovery Connect had an 81.3% likelihood of retention, compared with 72.0% (P<.001) among those not linked. Linkage also significantly predicted higher treatment continuance and a greater number of daily doses taken during the first 7 and 30 days (P<.001). Low, moderate, and high engagement levels were associated with progressively higher 30-day retention compared with no engagement (P<.001). Conclusions: This study provides evidence that implementing Recovery Connect (Recovery Path) significantly enhances patient retention and treatment continuity in outpatient opioid use disorder care. Early linkage and engagement during the first week were strong predictors of positive outcomes, underscoring the value of early, proactive digital support. These findings reinforce the effectiveness of blended digital-clinical models, aligning with broader evidence that integrating remote monitoring enhances continuity of care and supports recovery. Policy implications include the need for reimbursement mechanisms, workflow integration, and ethical, privacy-preserving implementation to enable scalable and equitable adoption of digital tools in substance use treatment. Trial Registration: ClinicalTrials.gov NCT07140926; https://clinicaltrials.gov/ct2/show/NCT07140926
- Open Access
- 8 September 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e50649
Real-Time Exposure to Alcohol Content in Digital Media in Adolescents: Protocol for a Multiburst Ecological Momentary Assessment Study
Background: Digital media frequently contains positive portrayals of alcohol content, which has been shown to be associated with alcohol-related cognitions and behaviors. Because youth are heavy media consumers and have access to unsupervised, repeat viewing of media content on their personal mobile devices, it is critical to understand the frequency of encountering alcohol content in adolescents’ daily lives and how adolescents engage with the content. Objective: This paper outlines the study protocol for examining adolescents’ exposure to alcohol-related content in digital media within their natural environments. Methods: Adolescents (N=302; 31.8% boys, 16.2% nonbinary, 51.3% girls; 25.8% Asian, 3.6% American Indian, 21.5% Black, 4.6% other, 52% White, 25.8% Hispanic or Latinx; mean age 16.21, SD 0.77 y) enrolled in high school were recruited through social media to participate in a prospective study involving bursts of ecological momentary assessment (EMA) reports coupled with longer surveys. We conducted group orientation sessions via videoconference and online surveys, followed by a 21-day EMA period that included scheduled reports across 4 daily time blocks, as well as self-initiated reports on media exposure. Reports of alcohol content exposure included details about the platform, level of engagement, source characteristics, beliefs and perceived norms about the content, the viewing context, and whether the content was sponsored or branded. The participants submitted exposures to alcohol content as an image (screenshot or photo) or text description to be objectively coded. The participants completed a weekly online survey assessing alcohol use and related cognitions. EMA reports will be merged with coded image and text entries and with data from baseline, weekly, and follow-up surveys. Self-reported alcohol exposure will be explored descriptively, and differences in exposure tested across subgroups. Event-level data will be compared with random prompt data to examine differences at times of exposure versus nonexposure. Prospective associations between media alcohol content exposure and alcohol use will be explored over 1-week and 4-month time frames. Mediation of the association between media alcohol exposure and drinking will be tested to explore putative mechanisms. Results: EMA data collection took place from February 2022 to August 2023. Data management and preliminary analysis are ongoing. Preliminary data were disseminated through conference presentations in 2024-2025 and manuscripts are ongoing with full results anticipated to be published in 2025-2026. Conclusions: By characterizing adolescents’ real-world exposure to alcohol content in the media, the study provides critical information to develop and implement interventions to target youth behavior that are well suited to delivery via mobile devices. Next steps are to conduct focus groups to understand participants’ lived experience of exposure to media alcohol content and reactions to proposed intervention targets. This study and subsequent qualitative work will launch a program of research to counter the effects of alcohol-related media exposure as experienced by adolescents in an effort to minimize underage alcohol involvement. International Registered Report Identifier (IRRID): DERR1-10.2196/50649
- 8 September 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e50649
Open AccessReal-Time Exposure to Alcohol Content in Digital Media in Adolescents: Protocol for a Multiburst Ecological Momentary Assessment Study
Background: Digital media frequently contains positive portrayals of alcohol content, which has been shown to be associated with alcohol-related cognitions and behaviors. Because youth are heavy media consumers and have access to unsupervised, repeat viewing of media content on their personal mobile devices, it is critical to understand the frequency of encountering alcohol content in adolescents’ daily lives and how adolescents engage with the content. Objective: This paper outlines the study protocol for examining adolescents’ exposure to alcohol-related content in digital media within their natural environments. Methods: Adolescents (N=302; 31.8% boys, 16.2% nonbinary, 51.3% girls; 25.8% Asian, 3.6% American Indian, 21.5% Black, 4.6% other, 52% White, 25.8% Hispanic or Latinx; mean age 16.21, SD 0.77 y) enrolled in high school were recruited through social media to participate in a prospective study involving bursts of ecological momentary assessment (EMA) reports coupled with longer surveys. We conducted group orientation sessions via videoconference and online surveys, followed by a 21-day EMA period that included scheduled reports across 4 daily time blocks, as well as self-initiated reports on media exposure. Reports of alcohol content exposure included details about the platform, level of engagement, source characteristics, beliefs and perceived norms about the content, the viewing context, and whether the content was sponsored or branded. The participants submitted exposures to alcohol content as an image (screenshot or photo) or text description to be objectively coded. The participants completed a weekly online survey assessing alcohol use and related cognitions. EMA reports will be merged with coded image and text entries and with data from baseline, weekly, and follow-up surveys. Self-reported alcohol exposure will be explored descriptively, and differences in exposure tested across subgroups. Event-level data will be compared with random prompt data to examine differences at times of exposure versus nonexposure. Prospective associations between media alcohol content exposure and alcohol use will be explored over 1-week and 4-month time frames. Mediation of the association between media alcohol exposure and drinking will be tested to explore putative mechanisms. Results: EMA data collection took place from February 2022 to August 2023. Data management and preliminary analysis are ongoing. Preliminary data were disseminated through conference presentations in 2024-2025 and manuscripts are ongoing with full results anticipated to be published in 2025-2026. Conclusions: By characterizing adolescents’ real-world exposure to alcohol content in the media, the study provides critical information to develop and implement interventions to target youth behavior that are well suited to delivery via mobile devices. Next steps are to conduct focus groups to understand participants’ lived experience of exposure to media alcohol content and reactions to proposed intervention targets. This study and subsequent qualitative work will launch a program of research to counter the effects of alcohol-related media exposure as experienced by adolescents in an effort to minimize underage alcohol involvement. International Registered Report Identifier (IRRID): DERR1-10.2196/50649
- Open Access
- 4 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Implementation of a Mobile Digital Tool Supporting Medication for Opioid Use Disorder Treatment Improves Retention: Stepped-Wedge Cluster Randomized Controlled Trial (Preprint)
BACKGROUND Despite its proven efficacy, retention in medication for opioid use disorder (MOUD) remains low, with structural and systemic barriers—such as access to care and treatment setting—alongside individual factors, including personalization and motivation, contributing to high rates of discontinuation. Digital interventions offer a promising approach to address many of these barriers; however, robust evidence for their effectiveness in improving retention and engagement with treatment remains scarce. OBJECTIVE This study aims to evaluate the impact of Recovery Connect—a white-labeled version of Recovery Path and a digital remote patient monitoring app used as part of a blended treatment model for opioid use disorder—on patient retention, treatment continuance, and medication adherence. METHODS A stepped-wedge cluster randomized trial was conducted across 9 outpatient MOUD clinics, organized into 8 clusters. Clusters were sequentially transitioned from usual care to a digitally enhanced model incorporating Recovery Connect, which provided real-time monitoring, psychoeducational and skill-based content, and messaging between patients and clinicians. The primary outcome was 30-day retention in treatment following exposure (implementation of the app in the clinic), linkage (downloading and connecting to the app), or engagement (levels of app usage). Secondary outcomes included treatment continuance—defined as receiving at least 75% of expected doses—and the number of daily doses taken within the first 3, 7, and 30 days after admission. Cluster-controlled discrete-time survival analyses were conducted, adjusting for patient- and clinic-level covariates. RESULTS Patients admitted to clinics that had implemented the app (n=1205) showed increased retention (922/1205, 75.5%) compared with those in clinics that had not (203/319, 63.6%, P<.001). Patients who downloaded and linked with a mental health professional on Recovery Connect had an 81.3% likelihood of retention, compared with 72.0% (P<.001) among those not linked. Linkage also significantly predicted higher treatment continuance and a greater number of daily doses taken during the first 7 and 30 days (P<.001). Low, moderate, and high engagement levels were associated with progressively higher 30-day retention compared with no engagement (P<.001). CONCLUSIONS This study provides evidence that implementing Recovery Connect (Recovery Path) significantly enhances patient retention and treatment continuity in outpatient opioid use disorder care. Early linkage and engagement during the first week were strong predictors of positive outcomes, underscoring the value of early, proactive digital support. These findings reinforce the effectiveness of blended digital-clinical models, aligning with broader evidence that integrating remote monitoring enhances continuity of care and supports recovery. Policy implications include the need for reimbursement mechanisms, workflow integration, and ethical, privacy-preserving implementation to enable scalable and equitable adoption of digital tools in substance use treatment. CLINICALTRIAL ClinicalTrials.gov NCT07140926; https://clinicaltrials.gov/ct2/show/NCT07140926
- 4 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImplementation of a Mobile Digital Tool Supporting Medication for Opioid Use Disorder Treatment Improves Retention: Stepped-Wedge Cluster Randomized Controlled Trial (Preprint)
BACKGROUND Despite its proven efficacy, retention in medication for opioid use disorder (MOUD) remains low, with structural and systemic barriers—such as access to care and treatment setting—alongside individual factors, including personalization and motivation, contributing to high rates of discontinuation. Digital interventions offer a promising approach to address many of these barriers; however, robust evidence for their effectiveness in improving retention and engagement with treatment remains scarce. OBJECTIVE This study aims to evaluate the impact of Recovery Connect—a white-labeled version of Recovery Path and a digital remote patient monitoring app used as part of a blended treatment model for opioid use disorder—on patient retention, treatment continuance, and medication adherence. METHODS A stepped-wedge cluster randomized trial was conducted across 9 outpatient MOUD clinics, organized into 8 clusters. Clusters were sequentially transitioned from usual care to a digitally enhanced model incorporating Recovery Connect, which provided real-time monitoring, psychoeducational and skill-based content, and messaging between patients and clinicians. The primary outcome was 30-day retention in treatment following exposure (implementation of the app in the clinic), linkage (downloading and connecting to the app), or engagement (levels of app usage). Secondary outcomes included treatment continuance—defined as receiving at least 75% of expected doses—and the number of daily doses taken within the first 3, 7, and 30 days after admission. Cluster-controlled discrete-time survival analyses were conducted, adjusting for patient- and clinic-level covariates. RESULTS Patients admitted to clinics that had implemented the app (n=1205) showed increased retention (922/1205, 75.5%) compared with those in clinics that had not (203/319, 63.6%, P<.001). Patients who downloaded and linked with a mental health professional on Recovery Connect had an 81.3% likelihood of retention, compared with 72.0% (P<.001) among those not linked. Linkage also significantly predicted higher treatment continuance and a greater number of daily doses taken during the first 7 and 30 days (P<.001). Low, moderate, and high engagement levels were associated with progressively higher 30-day retention compared with no engagement (P<.001). CONCLUSIONS This study provides evidence that implementing Recovery Connect (Recovery Path) significantly enhances patient retention and treatment continuity in outpatient opioid use disorder care. Early linkage and engagement during the first week were strong predictors of positive outcomes, underscoring the value of early, proactive digital support. These findings reinforce the effectiveness of blended digital-clinical models, aligning with broader evidence that integrating remote monitoring enhances continuity of care and supports recovery. Policy implications include the need for reimbursement mechanisms, workflow integration, and ethical, privacy-preserving implementation to enable scalable and equitable adoption of digital tools in substance use treatment. CLINICALTRIAL ClinicalTrials.gov NCT07140926; https://clinicaltrials.gov/ct2/show/NCT07140926
- Open Access
- 17 June 2025
- Published by Center for Open Science in PsyArXiv
Implementation of Digital Tools in MOUD Improves 30-Day Retention: A Stepped-Wedge Cluster Randomized Trial
ObjectivesTo evaluate the impact on patient retention and treatment continuance of Recovery Connect, a digital remote patient monitoring app used as part of a blended treatment model.MethodsA stepped-wedge cluster randomized trial was conducted across nine outpatient OUD clinics organized into eight clusters. Clusters were sequentially graduated from usual care to a digitally-enhanced model incorporating Recovery Connect, which provided real-time monitoring, psychoeducational and skill based learning content, and messaging between patients and clinicians. The primary outcome was 30-day retention in treatment following either exposure (implementation of the app into the clinic), linkage (connecting the patient app with the clinician’s app), or engagement (levels of usage of the app). Secondary outcomes included treatment continuance and # daily doses within the first 3, 7 and 30 days. Cluster-controlled discrete-time survival analyses were used, adjusting for patient- and clinic-level covariates.ResultsPatients admitted to clinics which had implemented the app saw increased retention (74.8%) compared to those that had not (69.5%; p=.047). Patients who linked with a clinician on Recovery Connect had a 81.3% likelihood of retention, compared to 72.0% (p<.001) among those not linked. Linkage also significantly predicted higher continuance and number of daily doses taken in the first 7 and 30 days. Low, moderate and high engagement levels had progressively higher 30–day retention vs no retention (p<.001).ConclusionsRecovery Connect significantly enhanced patient retention and treatment continuance in OUD treatment. Implementing digital interventions can effectively complement traditional care methods, substantially improving clinical outcomes.
- 17 June 2025
- Published by Center for Open Science in PsyArXiv
Open AccessImplementation of Digital Tools in MOUD Improves 30-Day Retention: A Stepped-Wedge Cluster Randomized Trial
ObjectivesTo evaluate the impact on patient retention and treatment continuance of Recovery Connect, a digital remote patient monitoring app used as part of a blended treatment model.MethodsA stepped-wedge cluster randomized trial was conducted across nine outpatient OUD clinics organized into eight clusters. Clusters were sequentially graduated from usual care to a digitally-enhanced model incorporating Recovery Connect, which provided real-time monitoring, psychoeducational and skill based learning content, and messaging between patients and clinicians. The primary outcome was 30-day retention in treatment following either exposure (implementation of the app into the clinic), linkage (connecting the patient app with the clinician’s app), or engagement (levels of usage of the app). Secondary outcomes included treatment continuance and # daily doses within the first 3, 7 and 30 days. Cluster-controlled discrete-time survival analyses were used, adjusting for patient- and clinic-level covariates.ResultsPatients admitted to clinics which had implemented the app saw increased retention (74.8%) compared to those that had not (69.5%; p=.047). Patients who linked with a clinician on Recovery Connect had a 81.3% likelihood of retention, compared to 72.0% (p<.001) among those not linked. Linkage also significantly predicted higher continuance and number of daily doses taken in the first 7 and 30 days. Low, moderate and high engagement levels had progressively higher 30–day retention vs no retention (p<.001).ConclusionsRecovery Connect significantly enhanced patient retention and treatment continuance in OUD treatment. Implementing digital interventions can effectively complement traditional care methods, substantially improving clinical outcomes.
- Open Access
- 18 April 2024
- Published by Research Society on Marijuana in Cannabis
- Vol. 7 (2) , 38-50
Cross-substance Effects of Adolescent Exposure to Alcohol Content in Popular Movies on Cannabis Initiation
Objective: Alcohol is the most frequently depicted substance in the media, and adolescent exposure to alcohol in the media predicts alcohol use. There is relatively little research on exposure to cannabis in the media, but exposure to alcohol content may exert cross-substance effects on cannabis use. Given the social and health risks associated with early cannabis use, the present study aims to assess the cross-substance effects of exposure to alcohol media content on age of cannabis initiation. Method: A sample of 830 middle school students (53% female) reported on movie alcohol exposure and cannabis initiation longitudinally until high school completion. Discrete-time survival models examined whether movie alcohol exposure predicted subsequent initiation among students who were cannabis-naïve at baseline, controlling for demographic, social, and behavioral covariates. The interaction between sex and movie alcohol exposure was also explored. Results: One third (33%) of participants reported cannabis initiation with a mean of 5.57 estimated hours (SD = 4.29) of movie alcohol exposure. A 1-hour increase in movie exposure predicted a significant 16% increased probability of cannabis initiation in models adjusted for demographic variables and a significant 14% increase in models adjusted for demographic, behavioral, and social variables. No differences were observed across sex. Conclusions: Greater adolescent exposure to alcohol content in the media was associated with earlier cannabis initiation above and beyond other etiologically relevant demographic, behavioral, and social variables. The influence of cross-substance media exposures warrants further exploration and should be taken into consideration in the development of preventive interventions for youth substance use.
- 18 April 2024
- Published by Research Society on Marijuana in Cannabis
- Vol. 7 (2) , 38-50
Open AccessCross-substance Effects of Adolescent Exposure to Alcohol Content in Popular Movies on Cannabis Initiation
Objective: Alcohol is the most frequently depicted substance in the media, and adolescent exposure to alcohol in the media predicts alcohol use. There is relatively little research on exposure to cannabis in the media, but exposure to alcohol content may exert cross-substance effects on cannabis use. Given the social and health risks associated with early cannabis use, the present study aims to assess the cross-substance effects of exposure to alcohol media content on age of cannabis initiation. Method: A sample of 830 middle school students (53% female) reported on movie alcohol exposure and cannabis initiation longitudinally until high school completion. Discrete-time survival models examined whether movie alcohol exposure predicted subsequent initiation among students who were cannabis-naïve at baseline, controlling for demographic, social, and behavioral covariates. The interaction between sex and movie alcohol exposure was also explored. Results: One third (33%) of participants reported cannabis initiation with a mean of 5.57 estimated hours (SD = 4.29) of movie alcohol exposure. A 1-hour increase in movie exposure predicted a significant 16% increased probability of cannabis initiation in models adjusted for demographic variables and a significant 14% increase in models adjusted for demographic, behavioral, and social variables. No differences were observed across sex. Conclusions: Greater adolescent exposure to alcohol content in the media was associated with earlier cannabis initiation above and beyond other etiologically relevant demographic, behavioral, and social variables. The influence of cross-substance media exposures warrants further exploration and should be taken into consideration in the development of preventive interventions for youth substance use.
- Open Access
- 5 April 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Real-Time Exposure to Alcohol Content in Digital Media in Adolescents: Protocol for a Multiburst Ecological Momentary Assessment Study (Preprint)
BACKGROUND Digital media frequently contains positive portrayals of alcohol content, which has been shown to be associated with alcohol-related cognitions and behaviors. Because youth are heavy media consumers and have access to unsupervised, repeat viewing of media content on their personal mobile devices, it is critical to understand the frequency of encountering alcohol content in adolescents’ daily lives and how adolescents engage with the content. OBJECTIVE This paper outlines the study protocol for examining adolescents’ exposure to alcohol-related content in digital media within their natural environments. METHODS Adolescents (N=302; 31.8% boys, 16.2% nonbinary, 51.3% girls; 25.8% Asian, 3.6% American Indian, 21.5% Black, 4.6% other, 52% White, 25.8% Hispanic or Latinx; mean age 16.21, SD 0.77 y) enrolled in high school were recruited through social media to participate in a prospective study involving bursts of ecological momentary assessment (EMA) reports coupled with longer surveys. We conducted group orientation sessions via videoconference and online surveys, followed by a 21-day EMA period that included scheduled reports across 4 daily time blocks, as well as self-initiated reports on media exposure. Reports of alcohol content exposure included details about the platform, level of engagement, source characteristics, beliefs and perceived norms about the content, the viewing context, and whether the content was sponsored or branded. The participants submitted exposures to alcohol content as an image (screenshot or photo) or text description to be objectively coded. The participants completed a weekly online survey assessing alcohol use and related cognitions. EMA reports will be merged with coded image and text entries and with data from baseline, weekly, and follow-up surveys. Self-reported alcohol exposure will be explored descriptively, and differences in exposure tested across subgroups. Event-level data will be compared with random prompt data to examine differences at times of exposure versus nonexposure. Prospective associations between media alcohol content exposure and alcohol use will be explored over 1-week and 4-month time frames. Mediation of the association between media alcohol exposure and drinking will be tested to explore putative mechanisms. RESULTS EMA data collection took place from February 2022 to August 2023. Data management and preliminary analysis are ongoing. Preliminary data were disseminated through conference presentations in 2024-2025 and manuscripts are ongoing with full results anticipated to be published in 2025-2026. CONCLUSIONS By characterizing adolescents’ real-world exposure to alcohol content in the media, the study provides critical information to develop and implement interventions to target youth behavior that are well suited to delivery via mobile devices. Next steps are to conduct focus groups to understand participants’ lived experience of exposure to media alcohol content and reactions to proposed intervention targets. This study and subsequent qualitative work will launch a program of research to counter the effects of alcohol-related media exposure as experienced by adolescents in an effort to minimize underage alcohol involvement. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/50649
- 5 April 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessReal-Time Exposure to Alcohol Content in Digital Media in Adolescents: Protocol for a Multiburst Ecological Momentary Assessment Study (Preprint)
BACKGROUND Digital media frequently contains positive portrayals of alcohol content, which has been shown to be associated with alcohol-related cognitions and behaviors. Because youth are heavy media consumers and have access to unsupervised, repeat viewing of media content on their personal mobile devices, it is critical to understand the frequency of encountering alcohol content in adolescents’ daily lives and how adolescents engage with the content. OBJECTIVE This paper outlines the study protocol for examining adolescents’ exposure to alcohol-related content in digital media within their natural environments. METHODS Adolescents (N=302; 31.8% boys, 16.2% nonbinary, 51.3% girls; 25.8% Asian, 3.6% American Indian, 21.5% Black, 4.6% other, 52% White, 25.8% Hispanic or Latinx; mean age 16.21, SD 0.77 y) enrolled in high school were recruited through social media to participate in a prospective study involving bursts of ecological momentary assessment (EMA) reports coupled with longer surveys. We conducted group orientation sessions via videoconference and online surveys, followed by a 21-day EMA period that included scheduled reports across 4 daily time blocks, as well as self-initiated reports on media exposure. Reports of alcohol content exposure included details about the platform, level of engagement, source characteristics, beliefs and perceived norms about the content, the viewing context, and whether the content was sponsored or branded. The participants submitted exposures to alcohol content as an image (screenshot or photo) or text description to be objectively coded. The participants completed a weekly online survey assessing alcohol use and related cognitions. EMA reports will be merged with coded image and text entries and with data from baseline, weekly, and follow-up surveys. Self-reported alcohol exposure will be explored descriptively, and differences in exposure tested across subgroups. Event-level data will be compared with random prompt data to examine differences at times of exposure versus nonexposure. Prospective associations between media alcohol content exposure and alcohol use will be explored over 1-week and 4-month time frames. Mediation of the association between media alcohol exposure and drinking will be tested to explore putative mechanisms. RESULTS EMA data collection took place from February 2022 to August 2023. Data management and preliminary analysis are ongoing. Preliminary data were disseminated through conference presentations in 2024-2025 and manuscripts are ongoing with full results anticipated to be published in 2025-2026. CONCLUSIONS By characterizing adolescents’ real-world exposure to alcohol content in the media, the study provides critical information to develop and implement interventions to target youth behavior that are well suited to delivery via mobile devices. Next steps are to conduct focus groups to understand participants’ lived experience of exposure to media alcohol content and reactions to proposed intervention targets. This study and subsequent qualitative work will launch a program of research to counter the effects of alcohol-related media exposure as experienced by adolescents in an effort to minimize underage alcohol involvement. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/50649
- 1 November 2023
- Published by American Psychological Association (APA) in Psychological Assessment
- Vol. 35 (11) , 1019-1029
The Epidemic–Pandemic Impacts Inventory (EPII): A multisample study examining pandemic-related experiences and their relation to mental health.
The Epidemic-Pandemic Impacts Inventory (EPII) was developed to assess pandemic-related adverse and positive experiences across several key domains, including work/employment, home life, isolation, and quarantine. Several studies have associated EPII-assessed pandemic-related experiences with a wide range of psychosocial factors, most commonly depressive and anxiety symptoms. The present study investigated the degree to which specific types of COVID-19 pandemic-related experiences may be associated with anxiety and depression risk, capitalizing on two large, independent samples with marked differences in sociodemographic characteristics. The present study utilized two adult samples: participants (N = 635) recruited online over a 4-week period in early 2020 (Sample 1) and participants (N = 908) recruited from the student body of a large Northeastern public university (Sample 2). We employed a cross-validated, least absolute shrinkage and selection operator (LASSO) regression approach, as well as a random forest (RF) machine learning algorithm, to investigate classification accuracy of anxiety/depression risk using the pandemic-related experiences from the EPII. The LASSO approach isolated eight items within each sample. Two items from the work/employment and emotional/physical health domains overlapped across samples. The RF approach identified similar items across samples. Both methods yielded acceptable cross-classification accuracy. Applying two analytic approaches on data from two large, sociodemographically unique samples, we identified a subset of sample-specific and nonspecific pandemic-related experiences from the EPII that are most predictive of concurrent depression/anxiety risk. Findings may help to focus on key experiences during future public health disasters that convey greater risk for depression and anxiety symptoms. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
- 1 November 2023
- Published by American Psychological Association (APA) in Psychological Assessment
- Vol. 35 (11) , 1019-1029
The Epidemic–Pandemic Impacts Inventory (EPII): A multisample study examining pandemic-related experiences and their relation to mental health.
The Epidemic-Pandemic Impacts Inventory (EPII) was developed to assess pandemic-related adverse and positive experiences across several key domains, including work/employment, home life, isolation, and quarantine. Several studies have associated EPII-assessed pandemic-related experiences with a wide range of psychosocial factors, most commonly depressive and anxiety symptoms. The present study investigated the degree to which specific types of COVID-19 pandemic-related experiences may be associated with anxiety and depression risk, capitalizing on two large, independent samples with marked differences in sociodemographic characteristics. The present study utilized two adult samples: participants (N = 635) recruited online over a 4-week period in early 2020 (Sample 1) and participants (N = 908) recruited from the student body of a large Northeastern public university (Sample 2). We employed a cross-validated, least absolute shrinkage and selection operator (LASSO) regression approach, as well as a random forest (RF) machine learning algorithm, to investigate classification accuracy of anxiety/depression risk using the pandemic-related experiences from the EPII. The LASSO approach isolated eight items within each sample. Two items from the work/employment and emotional/physical health domains overlapped across samples. The RF approach identified similar items across samples. Both methods yielded acceptable cross-classification accuracy. Applying two analytic approaches on data from two large, sociodemographically unique samples, we identified a subset of sample-specific and nonspecific pandemic-related experiences from the EPII that are most predictive of concurrent depression/anxiety risk. Findings may help to focus on key experiences during future public health disasters that convey greater risk for depression and anxiety symptoms. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
- Open Access
- 13 September 2023
- Published by Springer Nature in Addiction Science & Clinical Practice
- Vol. 18 (1) , 1-8
Early COVID-Related pandemic impacts and subsequent opioid outcomes among persons receiving medication for opioid use disorder: a secondary data analysis of a Type-3 hybrid trial
Background: Opioid overdoses have continued to increase since the start of the COVID-19 pandemic. The pathways through which the COVID-19 pandemic has affected trajectories of opioid use and opioid-related problems are largely unknown. Using the Epidemic-Pandemic Impacts Inventory (EPII), a novel instrument that assess pandemic-related impacts across multiple life domains, we tested the hypothesis that COVID-related impacts (on e.g., interpersonal conflict, employment, infection exposure, and emotional health) experienced in the early months of the pandemic would predict changes in opioid use and opioid-related problems at follow-up. Methods: This analysis was embedded within a cluster randomized type 3 implementation-effectiveness hybrid trial that had enrolled 188 patients across eight opioid treatments prior to the start of the pandemic. Participants had all been recently inducted on medication for opioid use disorder and were actively receiving treatment. Participants reported on their opioid use and opioid-related problems at baseline and 3-, 6-, and 9-month post-baseline assessments. Between May and August 2020, participants were sent an optional invitation to complete the EPII. Results: One hundred thirty-three respondents completed the EPII and 129 had sufficient data to analyze the EPII and at least one subsequent follow-up. In logistic and zero-inflated negative binomial analyses adjusting for covariates, each endorsed pandemic impact in the interpersonal conflict domain was associated with 67% increased odds of endorsement of any opioid use, and each impact in the employment and infection exposure-domains was associated with 25% and 75% increases in number of endorsed opioid-related problems, respectively. Conclusions: Mitigating the effect of the pandemic on patients’ interpersonal relationships and employment, and promoting greater infection control in opioid treatment programs, could be protective against negative opioid-related outcomes. Trial registration The present study describes secondary data analysis on a previously registered clinical trial: clinicaltrials.gov/ct2/show/NCT03931174.
- 13 September 2023
- Published by Springer Nature in Addiction Science & Clinical Practice
- Vol. 18 (1) , 1-8
Open AccessEarly COVID-Related pandemic impacts and subsequent opioid outcomes among persons receiving medication for opioid use disorder: a secondary data analysis of a Type-3 hybrid trial
Background: Opioid overdoses have continued to increase since the start of the COVID-19 pandemic. The pathways through which the COVID-19 pandemic has affected trajectories of opioid use and opioid-related problems are largely unknown. Using the Epidemic-Pandemic Impacts Inventory (EPII), a novel instrument that assess pandemic-related impacts across multiple life domains, we tested the hypothesis that COVID-related impacts (on e.g., interpersonal conflict, employment, infection exposure, and emotional health) experienced in the early months of the pandemic would predict changes in opioid use and opioid-related problems at follow-up. Methods: This analysis was embedded within a cluster randomized type 3 implementation-effectiveness hybrid trial that had enrolled 188 patients across eight opioid treatments prior to the start of the pandemic. Participants had all been recently inducted on medication for opioid use disorder and were actively receiving treatment. Participants reported on their opioid use and opioid-related problems at baseline and 3-, 6-, and 9-month post-baseline assessments. Between May and August 2020, participants were sent an optional invitation to complete the EPII. Results: One hundred thirty-three respondents completed the EPII and 129 had sufficient data to analyze the EPII and at least one subsequent follow-up. In logistic and zero-inflated negative binomial analyses adjusting for covariates, each endorsed pandemic impact in the interpersonal conflict domain was associated with 67% increased odds of endorsement of any opioid use, and each impact in the employment and infection exposure-domains was associated with 25% and 75% increases in number of endorsed opioid-related problems, respectively. Conclusions: Mitigating the effect of the pandemic on patients’ interpersonal relationships and employment, and promoting greater infection control in opioid treatment programs, could be protective against negative opioid-related outcomes. Trial registration The present study describes secondary data analysis on a previously registered clinical trial: clinicaltrials.gov/ct2/show/NCT03931174.